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Calcium signaling is pivotal to a host of physiological pathways. A rise in calcium concentration almost invariably
signals an increased cellular energy demand. Consistent with this, calcium signals mediate a number of pathways
that together serve to balance energy supply and demand. In pathological states, calcium signals can precipitate
mitochondrial injury and cell death, especially when coupled to energy depletion and oxidative or nitrosative stress.
This review explores themechanisms that couple cell signaling pathways tometabolic regulation or to cell death. The
significance of these pathways is exemplified by pathological case studies, such as those showing loss ofmitochondrial
calcium uptake 1 in patients and ischemia/reperfusion injury.
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Introduction
Mitochondrial function is crucial for energy provi-
sion and health in higher eukaryotes, particularly
in excitable cells, such as neurons, and in skele-
tal and cardiac muscle. Bioenergetic homeostasis,
which ensures that energy supply has the capacity
tomeet energy demand, is key to normal cell and tis-
sue health. Calcium signaling plays a central role in
both communicating increased energy demand and
in driving mechanisms that increase energy supply.
Calcium is a universal secondary messenger,
playing a central role in a remarkably wide range of
cellular processes, including muscular contraction,
fertilization, synaptic transmission, cell migration
and motility, and cell proliferation.1 Disordered
cytosolic calcium [Ca2+](c) signaling plays a critical
role in cell death. Mitochondria engage in an intri-
cate and complex dialoguewith calcium signals. The
capacity of mitochondria to accumulate calcium
was established many years ago through the work
of the pioneers of mitochondrial biology, including
Lehninger, Carafoli, and Attardi.2–4 More recent
research has placed this work into the context of
cell biology—the molecular identities of the major
components of these pathways havebeen elucidated,
and our understanding of the role of calcium sig-
naling in health and disease has grown immensely
in a short period of time. Since the pioneering
work of Rizzuto et al.5 and of other researchers in
the early 1990s,6–9 it has become clear that most
physiological calcium signals are associated with
mitochondrial calcium uptake. This association is
characterized as a true dialogue, in that calcium
signals shape mitochondrial bioenergetic function,
while mitochondrial calcium accumulation serves
as a fixed spatial buffer with the capacity to shape
the spatiotemporal patterning of calcium signals.
Calcium signals directly drive an increase in
mitochondrial bioenergetic efficiency through two
major pathways (Fig. 1), including one that is medi-
ated by the calcium-sensitive carrier SCaMC-3,
acting at the outer face of the inner mitochondrial
membrane (IMM) and therefore responding
directly to changes in [Ca2+](c). The other pathway,
mediated by the mitochondrial calcium uniporter
(MCU), requires a rise in matrix Ca2+ concen-
tration ([Ca2+](m)). The two pathways operate in
concert to increase oxidative phosphorylation in
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Figure 1. A schematic representation of the effect of calcium influx and efflux in mitochondria on respiration. Reproduced, with
permission, from Llorente Folch et al.83
response to cellular calcium signals. Thus, a rise
in [Ca2+](m) concentration drives the allosteric
activation of the three rate-limiting enzymes of
the tricarboxylic acid cycle: pyruvate, isocitrate,
and -ketoglutarate dehydrogenase.10 The Vmax of
pyruvate dehydrogenase, isocitrate dehydrogenase,
and -ketoglutarate dehydrogenase is enhanced
upon Ca2+ binding, upregulating the production
of reduced nicotinamide adenine dinucleotide
(NADH) and resulting in a subsequent increase
in mitochondrial membrane potential ( m),
followed by an increase in adenosine triphosphate
(ATP) production. This was demonstrated directly
in sensory neurons, where a calcium-dependent
increase in NADH fluorescence was observed
upon stimulation8 and was also shown to directly
increase ATP generation following calcium signals
associated with fertilization in the mammalian
oocyte.11 These mechanisms underlie a simple and
elegant direct coupling of ATP demand to increased
ATP supply mediated by calcium signaling.
A rise in [Ca2+](c) acts as a positive effector of
Ca2+-binding mitochondrial carriers (CaMCs),
including aspartate/glutamate carriers (AGCs) and
ATP-Mg/Pi carriers (SCaMCs). Aralar and citrin are
mammalian AGCs involved in the malate–aspartate
NADH shuttle, which promotes the transfer of
NADH from the cytosol to the mitochondria, thus
providing reducing power for ATP generation via
oxidative phosphorylation while also keeping the
cytosolic NADH/NAD+ ratio low, favoring gen-
eration of pyruvate and promoting mitochondrial
substrate supply. Cells overexpressing aralar and cit-
rin showed a larger increase in mitochondrial ATP
levels upon calcium stimulation compared to con-
trol cells, while mutants lacking Ca2+-binding sites
failed to show a significant energetic response to a
calcium signal.12 The ATP-Mg/Pi carriers are capa-
ble ofmodulating adenine nucleotide levels inmito-
chondria by exchanging cytosolic ATP-Mg2+ for
mitochondrial Pi in response to hormone-induced
calcium signaling.13,14 Therefore, mitochondrial
metabolism is integrated with calcium signaling by
the actions of both [Ca2+](m) and [Ca2+](c). Inter-
estingly, these also operate over different concen-
tration ranges: the S0.5 for the activation of aralar by
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Figure 2. A schematic of the sigmoidal dependence of mitochondrial calcium uptake on added calcium.MICU1 interacts with the
MCU through its N-terminal polybasic domain and establishes a threshold of intracellular calcium concentration formitochondrial
calcium uptake.31,84 The loss of MICU1 alleviates the threshold for uptake, meaning mitochondria are calcium loaded at rest and
uptake occurs in a more linear fashion. Adapted, with permission, from Csordas et al.32
calcium is approximately 300 nM,15 while the
intramitochondrial dehydrogenases are activated in
the micromolar range. As mitochondrial calcium
uptake is potential dependent and the potential will
amplify the rise in calcium concentration, modest
increases in cytosolic calcium are accompanied by
significantly greater increases in matrix calcium
concentration.
Mechanisms for mitochondrial calcium
uptake
Mitochondrial calcium uptake depends on the elec-
trochemical potential of Ca2+, dictated by the m
and by a low calcium concentration, which is main-
tained by a Na+/Ca2+ exchanger (NCX). While the
outer mitochondrial membrane (OMM) is perme-
able, some studies have suggested that the voltage-
dependent anion channel (VDAC) in the OMM
might act as aCa2+-activatedCa2+ channel.16,17 The
rise of [Ca2+](m) measured as a function of extrami-
tochondrial Ca2+ exhibits a sigmoidal relationship,
with a threshold at approximately 2–3M18 (Fig. 2).
These characteristics reflect the properties of the
MCU, which mediates the electrogenic movement
of calcium through the selectively permeable IMM.
Although mitochondrial calcium uptake was
first documented in the 1960s, the MCU was not
identified until 2011.19,20 The MCU consists of two
highly conserved transmembrane domains that are
predicted to oligomerize and form a tetrameric
gated ion channel in the IMM.21 While its over-
expression sensitizes cells to apoptotic stimuli,
silencing of the MCU has no effect on mitochon-
drial respiration, membrane potential, or basic
morphology,19,20 which may seem surprising given
its role in modulating energy demands. However, a
recent study showed that MCU knockdown in pan-
creatic islet cells lowered the expression of compo-
nents of the electron transport chain,22 suggesting
that the role of theMCU is tomediate the transfer of
peak [Ca2+](c) signals to the mitochondrial matrix
with little effect on resting [Ca2+](m).
Interestingly, it is possible to create viable mice in
which theMCU is globally knocked out (MCU-KO)
(although only when using an outbred strain23).
Despite a complete lack of capacity for mitochon-
drial calcium accumulation, the MCU-KO mice
showed no change in basal metabolism, mitochon-
drial morphology, autophagy, or protection from
cell death.24 The only reported physiological differ-
ence between MCU-KO mice and their wild-type
littermates (besides the KOs being smaller than the
wild-type mice) is that the MCU-KO mice showed
reduced maximal skeletal muscle power output,
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suggesting that altering matrix calcium in vivomay
be important in response to exercise.24 It is also
worthnoting that, in theMCU-KOmice,mitochon-
drial calcium responses to stimulation were reduced
but not completely abolished, suggesting the activ-
ity of other mechanisms mediating calcium uptake.
In contrast, recent work with cardiac-specific dele-
tion of the MCU demonstrated that the MCU is
required for cardiac ischemia/reperfusion injury via
irreversible mitochondrial permeability transition
pore (mPTP) opening. In addition, the MCU is
involved in the regulation of bioenergetic supply
in response to acute cardiac stress.25,26 Therefore,
recent results point to a role for the MCU in sup-
porting bioenergetic demand of cells and tissues.
Alongside the channel-forming MCU, a number
of regulatory proteins have been identified that
form part of a mitochondrial uniporter com-
plex, and their exact stoichiometry, role, and
interaction within the complex are still under
scrutiny. The MCU paralog MCUb (previously
known as CCDC109b) has been found to act as a
dominant negative subunit of the MCU channel.
The MCU/MCUb ratio appears to vary across
different tissues, potentially providing a molecular
mechanism to regulate the efficiency of mitochon-
drial calcium uptake.21 Mitochondrial calcium
uptake regulator 1 (MCUR1; previously known as
CCDC90A) was reported to be essential for MCU
function, as its knockdown diminished mitochon-
drial calcium uptake and compromised cellular
bioenergetics.27 However, recent work showed that
MCUR1 does not directly regulate the MCU, is
involved with the assembly of complex IV, and alters
mitochondrial calcium uptake as a consequence of
a decrease in mitochondrial membrane potential.28
Another proposed player in this regulatory network
is SLC25A23, an Mg/ATP-Pi carrier in the IMM,
which, as reported by Hoffman et al.,29 interacts
with the MCU and mitochondrial calcium uptake
1 (MICU1), and silencing of this carrier reduced
MCU-mediated mitochondrial calcium uptake.
MICU1physically interactswithMCUand shares
a similar tissue expression pattern.19 When initially
characterized, MICU1 was described as indispens-
able for mitochondrial calcium uptake;30 however,
subsequent studies have found this not to be the
case, and it is now widely agreed that MICU1
acts as a gatekeeper of the MCU by setting the
threshold concentration of intracellular calcium for
mitochondrial calcium uptake.31,32 By sensing cal-
cium levels with its two EF hands, MICU1 keeps the
MCU closed at low [Ca2+](c) (<3 M) but allows
cooperative activation of the channel as [Ca2+](c)
exceeds the threshold (Fig. 2).
Although MCU-KO mice may lack an obvi-
ous phenotype, the physiological importance of
mitochondrial calcium handling has been high-
lighted by research on the first human disease
to be associated with dysfunctional mitochondrial
calcium uptake. Individuals with loss-of-function
mutations in MICU1 present with a brain and
muscle disorder characterized by muscle weakness,
learning difficulties, and progressive extrapyrami-
dal motor disturbances.33 Typical features associ-
ated with mitochondrial disease were also reported
in some patients, including ataxia, microcephaly,
ophthalmoplegia, ptosis, optic atrophy, and axonal
peripheral neuropathy. Surprisingly, no patients
were reported to have diabetes mellitus, deafness, or
cardiomyopathy. Available muscle biopsies showed
myopathic features, including clusters of regenerat-
ing fibers and minicores.
Fibroblasts from two individuals lacking MICU1
(hereafter referred to as MICU1-KO) display a
striking mitochondrial phenotype; their mitochon-
dria are largely fragmented and calcium loaded,
even at basal unstimulated cytosolic calcium con-
centrations (Fig. 3). The sigmoidal dependence of
mitochondrial calcium uptake on calcium concen-
tration is also lost in these cells, consistent with the
previously characterized gatekeeping function of
MICU1. Despite demonstrating chronic activation
of the MCU, fibroblasts from MICU1-KO show
no change in mitochondrial membrane potential
or oxygen consumption. The cells appear to have
developed compensatory mechanisms to cope
with such mitochondrial stress, which is perhaps
reflected in the slow progression of clinical features
in affected individuals,33 but it is clearly imperative
to characterize function in the cell types primarily
affected by the mutation: neurons and muscle. The
neuromuscular phenotype of this mutation could
be attributed to the effects of aberrant calcium
signaling on calcium-dependent processes, such as
synaptic transmission and muscular contraction.
These are also tissues that undergo major changes
in energy demand on excitation and where reduced
capacity to respond to changing demand may have
the greatest effect on function.
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Figure 3. The loss of MICU1 results in increased basal mitochondrial calcium concentrations. Representative confocal image of
Rhod2-AM–labeled control (A) and MICU1-KO (B) fibroblasts. Scale bar indicates 20 m.
The identification of neuromuscular disease
associated with impaired mitochondrial calcium
handling highlights an aspect of mitochondrial
calcium signaling that tends to be ignored, which
is that mitochondrial calcium accumulation carries
an energetic cost. An increase in matrix Ca2+
inevitably leads to activation of efflux pathways,
most notably the Na+/Ca2+ exchange. This increase
will raise matrix Na+, which will in turn activate
mitochondrial Na+/H+ exchange, bringing protons
back into the matrix through a route that bypasses
the ATP synthase, consuming proton motive force
to balance calcium influx at the expense of ATP
synthesis. In patients, it seems probable that the
continuous transfer of Ca2+ into the matrix even
at resting [Ca2+](c) is sufficient to drive a futile
cycle where calcium is brought into the matrix and
(indirectly) exchanged for protons, undermining
the bioenergetic capacity of the cell. These observa-
tions illuminate the physiological role of MICU1,
which serves as a signal-to-noise discriminator for
mitochondrial calcium signaling and protects mito-
chondria from energetically wasteful basal calcium
uptake.
Mitochondrial permeability transition pore
Pathological and excessive mitochondrial calcium
uptake is a major trigger for cell death and is
mediated by the mPTP. Opening of the mPTP
has been implicated in cell death associated with
ischemia/reperfusion injury,34,35 neurodegenerative
disorders such as Alzheimer’s disease and Parkin-
son’s disease,36 several forms of muscular dystrophy
and myopathy,37 and diabetes.38 Indeed, it seems
to be a final common step in the pathway to
necrotic cell death. Although permeability transi-
tion was first described in the 1970s in a series
of seminal experiments carried out by Haworth
and Hunter,39–41 it has only been in the last two
decades that the role of themPTP has been intensely
studied in both necrotic and apoptotic cell death.
Permeability transition reflects the formation of a
nonspecific high-conductance channel in the IMM,
whichallowsunrestrictedmovementof solutesup to
1.5 kDa in size,39,42,43 resulting in the collapse of
 m, mitochondrial swelling due to the osmotic
influx of water, and induction of ATP hydrolysis
by the FoF1 ATPase. Mitochondrial swelling can
cause rupture of the OMM, releasing proapoptotic
factors, such as cytochrome c, apoptosis-inducing
factor, and procaspases from the intermembrane
space. It has been suggested that a reversible low-
conductance state of the mPTP might play a physi-
ological role in calcium signaling,44 while the high-
conductance state results in an irreversible mito-
chondrial catastrophe. Transient opening of the
mPTP has been implicated in calcium-induced cal-
cium release from mitochondria, likely preventing
mitochondrial calciumoverload.45 In particular, the
role of the mPTP in myocardial preconditioning–
induced protection has been well documented.46–48
Pore opening is primarily triggered by increased
[Ca2+](m), as well as by oxidative stress, increased
phosphate levels, loss of  m, and ATP depletion,
which can lower the Ca2+ threshold required
to trigger pore opening. Importantly, pore
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opening is limited by cyclosporine A (CsA), an
immunosuppressant drug in widespread clinical
use. Therefore, the mPTP represents an exciting
pharmacological target with translational potential.
A modulator of the mPTP was identified by studies
that demonstrated that the archetypal mPTP
inhibitor, CsA, worked through the inhibition of a
matrix peptidyl-prolyl cis–trans isomerase (PPIase),
cyclophilin D (CypD).49,50 Apart from cognitive
dysfunction due to decreased neurotransmission,51
CypD gene knockout mice show normal develop-
ment and almost no notable phenotype, raising
questions about the physiological role of CypD.
However, mitochondria isolated from CypD-
deficient mice reveal reduced sensitivity to pore
opening in response to increased [Ca2+](m) and
oxidative stress. Nonetheless, mPTP opening was
not completely abolished and could be provoked
by a higher [Ca2+](m).35
The molecular identity of the mPTP is still sub-
ject to debate. The VDAC and adenine nucleotide
translocase (ANT) were among the first candidate
components of the pore, as pharmacological mod-
ulators of ANT alter the probability of pore opening
and the ANT can adopt channel-like behavior in
response to excess calcium.52 An mPTP complex
comprising VDAC, ANT, and regulatory kinases
was proposed on the basis of reconstitution exper-
iments in liposomes.53 However, this model has
not endured the scrutiny of genetic studies. Specif-
ically, independent knockout experiments in mice
suggested that neither ANT nor VDAC is essential
for mPTP formation.54,55 He and Lemasters56 pro-
posed an alternativemechanism for pore formation,
proposing that damage by oxidative stress caused
misfolding of membrane proteins, which formed
amphipathic clusters regulated by chaperones such
as CypD. A role for the proposed regulator in the
OMM, the translocator protein (TSPO), was again
ruled out, as conditional knockout of the gene did
not alter sensitivity to permeability transition in
ischemia/reperfusion injury.57 Given the role of
inorganic phosphate as an inducer of permeability
transition, it is not surprising that the phosphate
carrier (PiC), through its interactions with ANT
and CypD, has been proposed as another candidate
component of the mPTP.58 Again, cardiac-specific
overexpression or knockdown inmice failed to alter
the mPTP response,59 and genetic ablation studies
in mice suggest that the PiC is not essential for
pore formation and may have a regulatory function
instead.60
More recently, it has been postulated that the F1Fo
ATP synthase may be the missing link in the com-
position of the mPTP complex. A study by Bernardi
and colleagues61 suggested that dimers of the ATP
synthase formed channels with similar properties as
the mPTP and also showed that CypD binds to the
oligomycin sensitivity–conferring protein (OSCP)
subunit of the F1Fo ATP synthase. Two indepen-
dent studies provided evidence to support a role
of the c-ring subunit of the F1Fo ATP synthase in
the permeability transition. In one of these stud-
ies, knockdown of the c-subunit resulted in HeLa
cells being more resistant to mPTP activation.62
Consistent with these data, Alavian et al.63 reported
that depletion of the c-subunit attenuated cell death
in neurons, whereas overexpression of a mutant
c-subunit with increased conductance resulted in
the opposite effect. These authors proposed that
the pore might be formed from a channel in the
c-ring exposed during the physical uncoupling of
the F1 and Fo subunits. While these new devel-
opments in the search for the identity of the pore
seem promising, knockdown of any component of
the intricate network of mitochondrial bioenergetic
pathways has complex downstream consequences
that complicate interpretation of the data. Detailed
studies of the various regulatory components of the
pore complex and their interactions are needed to
fully exploit the pharmacological potential of the
mPTP for combating disease.
Mitochondrial PTP opening in an
ischemia/reperfusion injury model
Despite challenges in defining the identity of, and
specific conditions for, mPTP assembly in isolated
mitochondria and cell-based models, the most
clearly defined role for pore opening is in the con-
text of ischemia/reperfusion injury. The primary
organs susceptible to mPTP-mediated ischemia/
reperfusion injury are the brain,64 kidney,65
liver,66 and heart,67 where mitochondrial health is
necessary for normal function.
Restriction of oxygen and nutrient delivery dur-
ing ischemia leads to progressive changes in cell
physiology that establish conditions that favor
opening of the mPTP at reperfusion. Thus, a
switch to anaerobic metabolism causes intracellu-
lar acidosis.68 The decrease in cellular pH activates
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Figure 4. Pathological changes during ischemia and reperfusion inmitochondria, leading to necrotic cell death viamPTP opening
in reperfusion.
the Na+/H+ exchanger (NHX), which removes pro-
tons but starts to raise intracellular Na+ ([Na+](i)).
The rise in [Na+](i) is exacerbated by slowed or
inactive Na+/K+ ATPase pumps as ATP is depleted
and also stimulates the NCX to reverse, increasing
intracellular calcium concentration ([Ca2+](i)).69,70
Therefore, there is a progressive increase in [Ca2+](i)
in cells within an infarct, which is coupled with
the depletion of ATP and adenine nucleotides, and
a progressive rise in inorganic phosphate. These
changes will ultimately culminate in necrotic—and
minor peripheral apoptotic—cell death, if ischemia
continues uninterrupted.71,72
Although the ischemic period of ischemia/
reperfusion injury induces significant intracellular
changes, the transitory phase of starvation primar-
ily sets the scene for mitochondrial dysfunction and
doesnot by itself necessarily drive irreversible injury.
Although primed, mPTP opening is prevented due
to the low intracellular pH during ischemia,73 while
mitochondrial calcium overload required to trig-
ger pore opening is limited, as the mitochondrial
membrane potential is inevitably dissipated by pro-
longed ischemia. Severe injury occurs during the
immediate aftermath of reperfusion, when oxygen
is reintroduced to the deprived region and oxidative
damage is initiated, a process sometimes described
as the oxygen paradox.74,75
At reperfusion, the reintroduction of oxygen
restores respiration, immediately restoring the
mitochondrial membrane potential and so driv-
ing rapid mitochondrial calcium uptake. The rise
in [Ca2+](c) may be further stoked by the genera-
tion of free radical species (reactive oxygen species,
or ROS), which stimulate calcium release from sar-
coplasmic stores.76 The increases in mitochondrial
calcium uptake combined with ROS generation,
alongwith restoration of physiological pH, are suffi-
cient to open the mPTP, depolarizing and disabling
mitochondrial ATP production, and causing cell
death.
Prevention of mPTP opening is an important
potential therapeutic target for the protection and
preservation of cells, especially in nonproliferat-
ing cardiomyocytes and neurons. As with many
complex cellular processes, numerous methods
have been used to broach the chain of events
that eventually lead to mPTP opening following
ischemia/reperfusion injury. Primarily, these proce-
dures have spanned preinjury priming events, from
remote77 and local preconditioning, to postinjury
salvaging measures including postconditioning78
and the use of antioxidants to neutralize excessive
ROS production. The mechanisms by which pre-
conditioning and postconditioning reduce infarc-
tion sizes are still unknown, although efforts have
beenmade in investigating cell signaling reperfusion
injury salvage kinase pathways and receptors such
as adenosine A1/A3, angiotensin II type I (AT1),
bradykinin, and -opioid receptors,79 as well as
SDF-1/CXCR480 and exosome signaling.81
Opening of themPTP at reperfusion is a response
to mitochondrial calcium overload in combina-
tion with high Pi, low ATP, and oxidative stress
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(Fig. 4). Recent work has identified themechanisms
involved in generating mitochondrial ROS at early
reperfusion. Comparative metabolomic analysis of
mouse tissues collected at ischemia and reperfu-
sion revealed the universal ischemia-specific accu-
mulation of several metabolites, namely, xanthine,
hypoxanthine, and succinate.82 Furthermore, path-
way analysis revealed that succinate is generated
through the metabolism of AMP through IMP to
generate fumarate, which is converted to succinate
at complex II of the respiratory chain.65 Measure-
ments ofROSgenerationusing confocalmicroscopy
in isolated rat cardiomyocytes during ischemia and
reperfusion (i.e.,measurement of the rate of appear-
ance of the fluorescent product of dihydroethidium
oxidation) showed that the rate of ROS generation
increased specifically at the onset of reperfusion and
was modulated by the accumulation of succinate in
mitochondria. Thus, incubation of cells with cell-
permeable dimethyl succinate increased the rate of
ROS generation at reperfusion, while inhibition of
complex II using dimethyl malonate—a competi-
tive inhibitor of succinate dehydrogenase (SDH)—
decreased the rate of ROS production upon reper-
fusion, as generation of succinate requires reversal
of SDH to metabolize accumulated fumarate. At
reperfusion, the reverse electron flow from SDH to
complex I is driven by the high levels of succinate
combined with limited capacity of the respiratory
chain due to depletion of adenine nucleotides. That
the reversed electron flow drives ROS generation at
complex I was confirmed, as ROS generation was
reduced by inhibition of complex I.
These experiments strongly suggest several
potential novel therapeutic targets in the pathway to
ROS generation that may help prevent mPTP open-
ing and cell death following reperfusion. The field
of mitochondrial biology faces the real prospect of
combining strategies to salvage cardiac tissue—and
likely tissues in other organ systems where the evi-
dence is currently less developed—at risk for injury
from ischemia.
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